MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$205,387K
(63.81%↑ Y/Y)
Change in unrealized
gain (loss) on...
$741K
(611.03%↑ Y/Y)
Net loss
-$204,627K
(63.97%↑ Y/Y)
Currency translation
adjustment
$1,501K
(379.52%↑ Y/Y)
Interest income
$21,430K
(-20.81%↓ Y/Y)
Other income
(expense)
$2,251K
Realized gain (loss) on
marketable securities
$5K
(141.67%↑ Y/Y)
Loss before income
taxes
-$204,627K
(63.97%↑ Y/Y)
Total other income,
net
$8,437K
(-65.83%↓ Y/Y)
License
$38,239K
Product
$24,663K
Interest expense
$13,682K
(3912.32%↑ Y/Y)
Change in fair value of
warrants liability
$812K
(-13.25%↓ Y/Y)
Investment advisory fees
$722K
(-26.02%↓ Y/Y)
Net loss on disposal
of fixed assets
-$33K
Loss from operations
-$213,064K
(64.05%↑ Y/Y)
Revenue
$62,902K
(698.96%↑ Y/Y)
Total costs and
expenses
$275,966K
(-53.50%↓ Y/Y)
Selling, general and
administrative
$151,562K
(118.92%↑ Y/Y)
Research and development
$115,106K
(16.13%↑ Y/Y)
Cost of
collaboration and license...
$8,442K
Cost of sales
$856K
Back
Back
Income Statement
source: myfinsight.com
Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. (NUVB)